MetLife, Inc.

New York Stock Exchange
Back to all articles
Very Bullish +85

MetLife Inc. stock gains on buyback plan and solid Q2 2026 figures

AI-generated analysis

📈 MetLife reported Q2 2026 earnings per share of USD 2.43, beating the consensus estimate of USD 2.37 by 2.53 percent.

💰 The Board of Directors authorized a new share buyback program of USD 3.0 billion on August 5, 2026.

📊 Quarterly revenue for Q2 2026 reached USD 13.52 billion, marking a 10.5 percent year-over-year increase.

💵 MetLife declared a quarterly dividend of USD 0.5925 per share, corresponding to an annualized yield of 2.4 percent.

🎯 Analysts maintain a consensus Buy rating with a target price of USD 102.21, indicating modest upside potential.

🏦 Institutional investors and hedge funds collectively own 94.99 percent of MetLife's outstanding shares.

📈 NEOS Investment Management LLC increased its stake by 13.5 percent in Q2 2026, purchasing an additional 10,646 shares.

🏢 MetLife operates as a global provider of insurance, annuities, and employee benefit programs with a broad product set.

📉 The stock is trading at USD 97.51, near the upper end of its projected 2026 range between USD 90.59 and USD 114.12.

Bullish Signals
  • MetLife beat Q2 2026 earnings expectations with EPS of USD 2.43 versus a consensus of USD 2.37, demonstrating strong operational performance.
  • The company generated quarterly revenue of USD 13.52 billion in Q2 2026, achieving a robust 10.5 percent year-over-year growth rate.
  • MetLife's Board authorized a substantial USD 3.0 billion share buyback program, allowing the repurchase of up to 4.8 percent of outstanding shares.
  • The insurer declared a quarterly dividend of USD 0.5925 per share, providing an attractive annualized yield of 2.4 percent to income-focused investors.
  • Analyst consensus maintains a Buy rating with a target price of USD 102.21, suggesting incremental upside from the current trading level of USD 97.51.
  • Institutional ownership remains high at 94.99 percent, and major investor NEOS Investment Management increased its stake by 13.5 percent in Q2 2026.
Full Analysis
MetLife Inc. shares are trading near the upper end of their recent range following a strong performance in Q2 2026, where the company reported earnings per share of USD 2.43, beating analyst consensus estimates by 2.53%. The results were released on August 5, 2026, providing investors with a fresh view of the insurer's profitability and capital generation capabilities. Beyond the earnings beat, MetLife announced a significant capital return strategy involving a USD 3 billion share buyback authorization approved by its Board of Directors. This program allows the company to repurchase up to 4.8 percent of its outstanding shares through open market purchases, signaling confidence in its financial position and commitment to shareholder value. Financial metrics for Q2 2026 highlight robust growth, with quarterly revenue reaching USD 13.52 billion, representing a 10.5 percent year-over-year increase. Additionally, the company declared a quarterly dividend of USD 0.5925 per share, offering an annualized yield of approximately 2.4 percent based on recent trading levels. Analyst sentiment remains positive with a consensus Buy rating and a target price of USD 102.21, suggesting potential medium-term upside from current levels. Institutional ownership stands at nearly 95 percent, while notable investors like NEOS Investment Management increased their stakes, reinforcing confidence in MetLife's earnings trajectory and capital return profile.